Q3 Earnings Forecast for Immunovant Issued By Zacks Research
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Equities researchers at Zacks Research boosted their Q3 2026 EPS estimates for shares of Immunovant in a research report issued on Thursday, December 18th. Zacks Research analyst Team now anticipates that the company will earn ($0.76) per share for the quarter, up from their prior forecast of ($0.77). […]
24 Dec 06:15 · The Markets Daily